体重指数与结核密切接触者结核发病风险
巴西多中心前瞻性队列纳入1846名肺结核患者密切接触者,随访24个月,25人(1.4%)进展为结核病。在未接受结核预防治疗的IGRA阳性接触者中,BMI与结核进展风险呈负相关(aHR=0.89),BMI<25 kg/m²者进展风险为BMI≥25者的4.14倍。
要点
- 未接受预防治疗是全人群结核进展的强危险因素(aHR=16.55)。
- IGRA阳性接触者BMI<25 kg/m²者结核进展风险显著高于BMI≥25者。
核心结论
- BMI<25 kg/m²是可简便获得的生物标志物,可识别IGRA阳性密切接触者中结核进展高风险人群。
- 优先对此高风险组开展结核预防治疗可能改善结核预防效果。
研究设计与样本
- 前瞻性多中心队列研究(RePORT-Brazil),2015至2019年纳入619例肺结核指示病例的1846名密切接触者,随访24个月。
- 采用经验性综述与LASSO回归进行降维,构建全接触者、基线IGRA阳性接触者、IGRA阳性且未接受预防治疗接触者三个预测模型,并用bootstrapping进行内部验证。
主要发现
- 1846名接触者中25人(1.4%)进展为结核病。
- 全接触者中未接受预防治疗是结核进展危险因素(混合效应校正风险比aHR=16.55,95%CI 2.22-124.45)。
- IGRA阳性接触者中BMI<25 kg/m²者结核进展风险为BMI≥25 kg/m²者的4.14倍(95%CI 1.17-14.67),进展率分别为8.4%与2.1%。
临床怎么用
- 对IGRA阳性密切接触者评估BMI,BMI<25 kg/m²者应优先考虑结核预防治疗。
- 确保密切接触者接受结核预防治疗,未治疗者进展风险显著升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Approximately 95% of people infected with Mycobacterium tuberculosis do not progress to tuberculosis (TB) disease. Identifying key determinants of TB progression could focus prevention efforts. METHODS: Contacts of pulmonary TB patients were enrolled in a prospective multi-center cohort study (Regional Prospective Observational Research in Tuberculosis [RePORT]-Brazil) from 2015 to 2019 and followed for 24 months. Empirical review and least absolute shrinkage and selection operator (LASSO) regression, using baseline clinical and laboratory information, were used as dimension reduction techniques to determine factors for inclusion in prediction models. Models were created for: (1) all contacts, (2) contacts interferon-gamma release assay (IGRA)-positive at baseline, and (3) IGRA-positive contacts who did not receive TB preventive therapy (TPT; <30 days isoniazid). Internal validation was performed using bootstrapping. RESULTS: Among 1846 contacts of 619 TB index patients, 25 (1.4%) progressed to TB. No TPT was a risk factor for progression to TB among all contacts (mixed-effects adjusted hazard ratio [aHR] = 16.55, 95% confidence interval [CI]: 2.22-124.45). Internal validation with all contacts yielded an area under the receiver operating characteristic curve of 0.80 (95% CI: .72-.86]. Body mass index (BMI) was inversely associated with increased risk of progressing to active TB among IGRA-positive contacts who did not receive TPT (aHR = 0.89, 95% CI: .80-.99). Interferon-gamma release assay-positive contacts with BMI <25 kg/m2 had a 4.14-fold (95% CI: 1.17-14.67) higher risk of progression to TB than IGRA-positive contacts with BMI ≥25 kg/m2: 8.4% versus 2.1%, respectively. CONCLUSIONS: Body mass index <25 kg/m2, a readily available biomarker, identified IGRA-positive close TB contacts at high risk of progressing to TB disease. Prioritizing this high-risk group for TB preventive therapy could improve TB prevention efforts. BMI <25 kg/m², a readily available biomarker, identified IGRA-positive close contacts at high risk for progression to TB in a large observational Brazilian cohort. Prioritizing this high-risk group for TB preventive therapy could significantly improve TB prevention efforts.
引用
- Arriaga MB, Amorim G, Figueiredo MC, et al. Body Mass Index and Incident Tuberculosis in Close Tuberculosis Contacts. Clin Infect Dis. 2026. PMID: 40898999. doi:10.1093/cid/ciaf475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。